Communicated by Maria Rita Passos-Bueno
Research Article
Branchio-oto-renal syndrome (BOR): novel mutations in the EYA1 gene, and a review of the mutational genetics of BOR†
Article first published online: 25 JAN 2008
DOI: 10.1002/humu.20691
© 2008 Wiley-Liss, Inc.
Issue
1098-1004/asset/cover.gif?v=1&s=b02ab57a64d28403f477b09d50f72a4d63f4c8eb)
Human Mutation
Special Issue: Focus on Pharmacogenetics
Volume 29, Issue 4, pages 537–544, April 2008
Additional Information
How to Cite
Orten, D. J., Fischer, S. M., Sorensen, J. L., Radhakrishna, U., Cremers, C. W., Marres, H. A., Van Camp, G., Welch, K. O., Smith, R. J. and Kimberling, W. J. (2008), Branchio-oto-renal syndrome (BOR): novel mutations in the EYA1 gene, and a review of the mutational genetics of BOR. Human Mutation, 29: 537–544. doi: 10.1002/humu.20691
- †
Publication History
- Issue published online: 10 MAR 2008
- Article first published online: 25 JAN 2008
- Manuscript Accepted: 31 OCT 2007
- Manuscript Received: 31 JAN 2007
Funded by
- National Institutes of Health (NIH)–National Institute of Dental and Craniofacial Research (NIDCR). Grant Number: 5R01DE014090-04
- NIH–National Institute on Deafness and Other Communication Disorders (NIDCD). Grant Numbers: 5R01DC003544-09, 5R01DC04293
Keywords:
- branchio-oto-renal syndrome;
- mutation analysis;
- genetic heterogeneity;
- EYA1
Abstract
Branchio-oto-renal syndrome (BOR) is an autosomal dominant disorder characterized by the association of branchial and external ear malformations, hearing loss, and renal anomalies. The phenotype varies from ear pits to profound hearing loss, branchial fistulae, and kidney agenesis. The most common gene mutated in BOR families is EYA1, a transcriptional activator. Over 80 different disease-causing mutations have been published (www.healthcare.uiowa.edu/labs/pendredandbor/, last accessed 20 November 2007). We analyzed the EYA1 coding region (16 exons) from 435 families (345 at the University of Iowa [UI] and 95 at Boys Town National Research Hospital [BTNRH], including five at both) and found 70 different EYA1 mutations in 89 families. Most of the mutations (56/70) were private. EYA1 mutations were found in 31% of families (76/248) fitting established clinical criteria for BOR and 7% of families with questionable BOR phenotype (13/187). Severity of the phenotype did not correlate with type of mutation nor with the domain involved. These results add considerably to the spectrum of EYA1 mutations associated with BOR and indicate that the BOR phenotype is an indication for molecular studies to diagnose EYA1-associated BOR. Hum Mutat 29(4), 537–544, 2008. © 2008 Wiley-Liss, Inc.

1098-1004/asset/HUMU_left.gif?v=1&s=4065e12063da1c0efe3c1a74d4f13c3cd92fba18)
1098-1004/asset/HUMU_right.gif?v=1&s=58026811b6aa5bee5a3d0e0563a705f8b681f34d)